Drug-based optical agents: infiltrating clinics at lower risk.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 22593172.
- Also identified by DOI 10.1126/scitranslmed.3003572.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Fluorescent agents with specificity to cellular and subcellular moieties present promise for enhancing diagnostics and theranostics, yet challenges associated with regulatory approvals of experimental agents stifle the clinical translation. As a result, targeted fluorescent agents have remained predominantly as preclinical imaging tools. We discuss the potential of using optically labeled drugs to accelerate the clinical acceptance of optical and optoacoustic agents, in analogy to nuclear medicine approaches. This strategy, corroborated with microdosing studies, outlines a promising approach for overcoming bottlenecks and advancing photonic clinical imaging.
Medical subject headings
- Fluorescent Dyes
- Pharmaceutical Preparations
- Translational Research, Biomedical